Main Street Group’s GSK GSK Stock Holding History

Main Street Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.41K	Hold	50	–	–	﹤0.01%	737
2026 Q2	$2.62K	Hold	50	–	–	﹤0.01%	713
2026 Q1	$2.76K	Buy	+50	New	+$2.71K	﹤0.01%	711
2025 Q4	–	Sell	-50	Closed	-$2.16K	–	303
2025 Q3	$2.16K	Hold	50	–	–	﹤0.01%	683
2025 Q2	$1.92K	Hold	50	–	–	﹤0.01%	647
2025 Q1	$1.94K	Hold	50	–	–	﹤0.01%	668
2024 Q4	$1.69K	Sell	50 -464	-90%	-$16.7K	﹤0.01%	663
2024 Q3	$21K	Hold	514	–	–	0.01%	396
2024 Q2	$19.7K	Hold	514	–	–	0.01%	411
2024 Q1	$21.8K	Buy	514 +50	+11%	+$2.06K	0.01%	421
2023 Q4	$17.2K	Buy	+464	New	+$16.7K	0.01%	669

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Main Street Group's GSK Position: Q3 2026 in Review

Main Street Group held its GSK (GSK) position steady in Q3 2026 at 50 shares worth $2.41K. The position accounts for ﹤0.01% of the portfolio, ranked #737.

Main Street Group first reported a position in GSK in Q4 2023 and has held it in 11 quarters since. The position peaked at $21.8K in Q1 2024. 654 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

Main Street Group held 50 shares of GSK worth $2.41K as of Q3 2026.
Main Street Group left its GSK share count unchanged in Q3 2026.
GSK made up ﹤0.01% of Main Street Group's portfolio in Q3 2026, its #737 holding.
Main Street Group first reported a position in GSK in Q4 2023 and has held it in 11 quarters since.
Main Street Group's GSK position peaked at $21.8K in Q1 2024.
654 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Main Street Group's 13F filing for Q3 2026, filed 28 Oct 2026.